Archive for February, 2019

$YGYI Khrysos Industries Reveals Expansion Plans

YGYI’s Khrysos Industries Reveals Expansion Plans with Closing of 45-Acre Tract of Land in Central Florida

The Multi-Purpose Site Will Be Home to Post Processing Tolling Facility, an R&D Facility Dedicated to Hemp Plant Genetic Research, a 5-Acre Greenhouse, and 20 Acres of Farmable Land for Future Use

SAN DIEGO, Feb. 28, 2019 — Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct, multi-vertical lifestyle company, announced today that its wholly-owned subsidiary, Khrysos Industries, has closed on a 45-acre tract of land in Central Florida. The company advised that it intends to move quickly to erect two separate, already contracted , pre-fabricated 2,800-square-foot buildings on the land – one of which will be dedicated as a revenue center focused on toll processing utilizing Khrysos’ new continuous flow post processing system.  This end-to-end industrial food grade stainless steel system combines falling film ethanol removal, wiped-film first and second-stage distillation, all in one system with estimated 480 liter production through put capacity.  The system also includes decarboxylation and filtration. The second building will be dedicated to hemp genetic research with the aim at increasing specific yields of certain cannabinoids.  This combined with the 5-acre greenhouse will allow for the production of tissue culturing and quality hemp seed production. Additionally, the company announced it has leased an 8,800 square foot facility in Central Florida that will serve as the assembly, manufacturing, and production facility for Khrysos’ one-ton Hyper Supercritical extraction systems.

“Today we start to unfold more aspects of Khrysos Industries’ capabilities and multiple revenue centers built into its business model,” said Dave Briskie, President and CFO of YGYI.    “This end-to-end post-processing facility  is designed to not only act as a profit center that will help meet the significant demand of processing hemp oil into non-THC isolate and distillate, but will also double as a working showroom for prospective clients to see our end-to-end systems in full-scale production.”

“This is an exciting time for Khrysos Industries as we focus on capitalizing on the shortage of production of non-THC oil into isolate and distillate and begin to address the growing shortage of quality tissue culturing and seed availability within the hemp industry,” said Dwayne Dundore, President of YGYI’s newly-formed Khyrsos Industries. “The pre-fabricated buildings are scheduled to be delivered to the site in the middle of March and the 5-acre greenhouse will begin to be assembled in early April. We anticipate pre-production processing beginning on a small scale in early April and ramping up to full production with our end-to-end system in early July,” Mr. Dundore continued. “We anticipate that our genetics research facility and our greenhouse production capabilities will be at full-scale in the production of tissue culturing and quality hemp seeds as we move into the 2020 growing season.”

About Youngevity International, Inc.
YGYI, Inc. (NASDAQ:YGYI), is an emerging conglomerate with a rapidly growing portfolio of consumer brands produced via in-house manufacturing and distributed by traditional and non-traditional channels including a multi country direct selling network. The brand has pioneered a hybrid of the direct-selling business model, and has a deep interest in e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.
To receive future press releases via email, please visit: https://ygyi.com/investors/email-alerts/

Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and includes statements regarding plans to erect two separate, already contracted , pre-fabricated 2,800-square-foot buildings on a 45-acre tract of land in Central Florida, to serve as an end-to-end post-processing facility and working showroom,  pre-production processing beginning on a small scale in early April and ramping up to full production with our end-to-end system in early July, and genetics research facility and greenhouse production capabilities being at full-scale in the production of tissue culturing and quality hemp seeds as we move into the 2020 growing season.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to quickly erect two separate, already contracted , pre-fabricated 2,800-square-foot buildings on the 45-acre tract of land in Central Florida, to serve as an end-to-end post-processing facility and working showroom,  our ability to commence pre-production processing beginning on a small scale in early April and ramping up to full production with our end-to-end system in early July, and our ability to implement our genetics research facility and greenhouse production capabilities at full-scale in the production of tissue culturing and quality hemp seeds by the 2020 growing season, our ability to continue our coffee segment growth, our ability to continue our international growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution,  , our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2017 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Contacts:
Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500
Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com

Thursday, February 28th, 2019 Uncategorized Comments Off on $YGYI Khrysos Industries Reveals Expansion Plans

$VVCIF Edmonton Cannabis “Notwithstanding Clause” – 420 with CNW

Barely four months after recreational cannabis was legalized in Canada, the city of Edmonton has made a proposal to include a “notwithstanding clause” in the law that stipulates the distance between cannabis retail shops and other public facilities, such as libraries and schools.

The current separation distances stipulated in the city’s bylaws state that there should be at least 200 meters between cannabis retail stores and schools or libraries. The law also stipulates that there should be at least 100 meters between a cannabis retail shop and provincial healthcare sites, parks and other public recreation facilities.

While the approach included in the existing laws is important in keeping minors from accessing cannabis, it is woefully inadequate when one considers large shopping malls and undeveloped land that hasn’t been subdivided as yet.

For example, the existing laws would prevent a cannabis retail facility from being opened in a large mall if that mall was close to a library. The exception clause being advocated for could address such unique situations.

There is no intention to change the rule stating that the distance between one cannabis retail shop and the next one should be at least 200 meters, but the “notwithstanding clause” will clarify how that separation distance is arrived at for different situations.

Such calls for amendments are to be expected when something new like recreational cannabis is first legalized. It is not possible for the framers of the original law to anticipate every possible situation, so the proposed amendments provide an avenue to iron out any kinks that may have been overlooked earlier.

As these calls for city bylaw amendments make their way through the system, the shortages of cannabis throughout the country are still ongoing. However, there is hope that the supply shortages will diminish over the coming months as the different licensed producers begin harvesting from the additional cultivation facilities that they rushed to commission as soon as retailers run out of cannabis a day after recreational cannabis was legalized.

In the meantime, the federal government is beginning to consider draft proposals for the regulation of cannabis edibles in the country. This segment of the industry was left out and there was a promise that an appropriate regulatory framework would be in place one year after recreational cannabis hit the shelves.

TransCanna Holdings Inc. (CSE: TCAN), VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and the entire cannabis industry look forward to the outcome of the amendments proposed in Edmonton since those changes may make it easier for residents to have a retail facility close by.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Thursday, February 28th, 2019 Uncategorized Comments Off on $VVCIF Edmonton Cannabis “Notwithstanding Clause” – 420 with CNW

$NUGS Carves Out Additional California Cannabis Cultivation

Cannabis industry incubator Cannabis Strategic Ventures (OTC: NUGS) is preparing cultivation sites in California from San Francisco to Los Angeles. A recent article discussing the company reads, “Drive 400 miles from San Francisco to Los Angeles anytime soon, and you may be passing through Cannabis Strategic Ventures Inc. (OTC: NUGS) land. The Golden State incubator and brand builder is set to benefit from a large batch of licenses awarded in cannabis-friendly communities along the stretch. Recently, NUGS announced that it had signed a letter of intent to partner with a Santa Barbara County grow operation that holds approximately 40 commercial cannabis licenses from the County of Santa Barbara, the California Bureau of Cannabis Control, the Manufactured Cannabis Safety Branch and the CalCannabis Cultivation (http://nnw.fm/g3YEv). This impending deal signals NUGS’ commitment to its strategy of promoting brands to be category leaders in the recreational and medical cannabis sectors. The NUGS management team believes that the cultivation sites will eventually be a critical component of each brand’s supply chain.”

To view the full article, visit: http://nnw.fm/Z4gbL

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, February 28th, 2019 Uncategorized Comments Off on $NUGS Carves Out Additional California Cannabis Cultivation

$RIV $RIV.V $CNPOF Releases Q3 Financial Highlights and Corporate Update

Dynamic plant-based food and beverage company Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Wednesday released its financial results for the three and nine months ended December 31, 2018. Per the update, Canopy Rivers’ full Management’s Discussion and Analysis (“MD&A”) and unaudited interim consolidated financial statements for the period are available on its SEDAR profile at www.SEDAR.com and via the company’s website. “With more than $55 million of capital deployed during the quarter, Canopy Rivers continues to position itself as a preeminent investment firm in the cannabis industry,” RIV Chief Financial Officer Eddie Lucarelli said in the news release. “As we continue to see meaningful developments at our portfolio companies, the closing of our bought deal financing and strategic investment from Canopy Growth will add additional strength to our balance sheet. With a strong pipeline of investment opportunities and regulatory reform continuing around the world, Canopy Rivers is optimally positioned to continue to prudently deploy capital to the global cannabis sector.”

To view the full press release, visit: http://nnw.fm/OWnY6

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, February 28th, 2019 Uncategorized Comments Off on $RIV $RIV.V $CNPOF Releases Q3 Financial Highlights and Corporate Update

$TGODF Maintains Lofty Growth Expectations for 2019

  • The Green Organic Dutchman is building on a series of agreements to scale up its cannabis production operations in Canada, Jamaica, Europe and Latin America
  • The Company’s first crop goes on sale soon to an exclusive loyalty group of patients and investors
  • The Dutchman’s production strategy envisions 80,000 kilograms of cultivation by the end of this year en route to 219,000-kilogram buildout by 2021
  • The company’s focus is on a premium organic brand built to high standards of environmental friendliness

Canada’s prime mover efforts to legalize the use of cannabis nationwide, not only as a medicinal substance but also as a wellness-enhancing consumable and a recreational drug, has made it a fertile field for entrepreneurial innovation and a friend to innovative business operations such as The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) – an Ontario-based producer of 100 percent-certified organic cannabis with an expanding footprint.

The Green Organic Dutchman, also known simply by its ticker, ‘TGOD’, was described by cannabis news outlet The Motley Fool last year as one of Canada’s top seven marijuana growers, thanks largely to the company’s plans to…

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, February 28th, 2019 Uncategorized Comments Off on $TGODF Maintains Lofty Growth Expectations for 2019

$TGODF NetworkNewsWire Releases Exclusive Audio Interview

NEW YORK, Feb. 28, 2019 — via NetworkWire – NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) (TGOD Profile), a client of NNW and a premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market.

The interview can be heard at http://nnw.fm/r6ABR.

NNW’s Stuart Smith opens the interview with an introduction to TGOD CEO Brian Athaide, who recaps several recent milestones and how they feed into the Company’s broader goals.

“We’ve come a long way if you look at progress on our two facilities in Canada … We’ve been doing a lot of work in getting those facilities further along and actually have done a lot of redesign work based on learnings in the industry … where people are facing bottlenecks and operational issues,” Athaide says, noting that these efforts successfully increased TGOD’s Canadian production capacity to more than 200,000 kilos.

In October 2018, TGOD acquired HemPoland, a leading European manufacturer and marketer of premium organic CBD oils, providing the Company a strategic pathway into the European market.

“We’re really establishing our business there by expanding the brand Cannabigold that we acquired from HemPoland and creating the sales and distribution infrastructure that we can then launch our TGOD THC brand on top of that, as more and more countries become legal from a medical cannabis side,” says Athaide.

In Denmark, TGOD’s joint-venture production partner, Knud Jepsen, was granted an initial cannabis business authorization. This license was a green light for Knud Jepsen to immediately begin importation of starting materials and to begin research and development related to the creation of elite cannabis genetics.

“We are partnering with … Knud Jepsen, and they’ve been in the agricultural business growing flowers for about 80 years in greenhouses and have a lot of great capabilities … that we believe will be transferable to cannabis,” Athaide explains. “We’re looking forward to partnering with them in cultivating in Denmark for the Danish market, and then we’re also looking at other places where we can cultivate at much lower cost in Europe … so we’re progressing well with our European strategy.”

TGOD also has interests in Mexico, where the Company has reached a joint-venture agreement with one of the country’s largest pharmaceutical distributors. The joint venture is expected to provide TGOD more than 7,000 points of distribution in the country and create an “early mover advantage” should the new government legalize recreational cannabis.

On par with its operational advances, TGOD kicked-off 2019 with several internal achievements.

“We’ve reached the point where we’re close to launching our brand … we’re now ready to go to the next stage,” says Athaide, who then discusses additions to the Company’s leadership to execute the next phase of development.

As host Smith notes, listeners can learn more about Athaide and the rest of the Company’s management team in an earlier NNW audio interview at http://nnw.fm/I4q8y.

“You need to give it a good listen, because this is a great management team pushing forward a very ambitious company,” says Smith.

Wrapping up the interview, Smith asks Athaide to discuss the state of the cannabis industry. Athaide forecasts that the crowded cannabis industry will shrink in size, with only the fittest companies prevailing.

TGOD’s proven leadership, scalability and focus on premium organic crop, he says, will differentiate the Company from others.

“There’s a lot of news in this industry … a lot of money being raised and deployed, but it’s really going to come down to execution in terms of who will be able to actually succeed and last in this market,” he says. “That’s what we’re focused on, is really being able to execute with excellence … We’re focused on really dominating that organic segment within the market.”

About the Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

About NetworkNewsAudio

 NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Thursday, February 28th, 2019 Uncategorized Comments Off on $TGODF NetworkNewsWire Releases Exclusive Audio Interview

$GGBXF Reports Second Quarter Fiscal 2019 Results Available

COLUMBUS, OH, Feb. 27, 2019  – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) today released results for Second Quarter 2019 ended December 31, 2018. Condensed Interim Consolidated Financial Statements, Management Discussion & Analysis, and a Letter to Shareholders from CEO, Peter Horvath, are available on Green Growth Brands’ Investor Relations website and SEDAR.

In conjunction with release of the financials, GGB Management will host a question and answer conference call and audio webcast at 8:30 AM EST on Thursday, February 28, 2019.

Conference Call Information:

Conference ID: 34499342
Local Toronto Dial-in Number: (+1) 416 764 8609
Local Vancouver Dial-in Number: (+1) 778 383 7417
North American Toll-Free Number:(+1) 888 390 0605

The call and replay archive can also be accessed on Green Growth Brands Investor Relations website.

About Green Growth Brands
Green Growth Brands expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love. Led by Peter Horvath, the GGB team is full of retail and consumer packaged goods experts with decades of experience building successful brands. Join the movement at GreenGrowthBrands.com.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions.   Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Wednesday, February 27th, 2019 Uncategorized Comments Off on $GGBXF Reports Second Quarter Fiscal 2019 Results Available

$YGYI Announces Expansion of Café Cachita Brand

Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) this morning announced the expansion of its recently acquired Café Cachita brand of espresso into over 500 retail locations through Southeastern Grocers. Per the update, the new distribution footprint will include all Winn Dixie, Bi-Lo, Fresco Y Mas and Harvey Stores across Florida, Georgia, Alabama, Louisiana, Mississippi, North Carolina and South Carolina. “Café La Rica is really beginning to gain traction. Our foot print in Florida and the Southeast has been growing steadily and this is beginning to have a ripple effect into the West Coast and the Northeast as these geographical regions are beginning to support our brand,” Dave Briskie, president and CFO of YGYI, stated in the news release. “Our strategy of adding Café Cachita to our brand portfolio is designed to command more shelf space in the espresso category at retail. We appreciate the early success.”

To view the full press release, visit: http://nnw.fm/9srAA

About Youngevity International, Inc.

Youngevity International, Inc. is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, February 27th, 2019 Uncategorized Comments Off on $YGYI Announces Expansion of Café Cachita Brand

$TGODF $TGOD.V North American Hemp-CBD Imports and Exports Projected To Jump

Palm Beach FL –February 27, 2019 – The recent reports that projected the CBD markets will hit $22 billion by 2022 also predict that the world CBD markets could outpace marijuana… or recreational cannabis. This is not only good news for North American cannabis companies regarding domestic sales, but also for international sales. North American companies will become players in the worldwide import and export markets as well. A recent publication by an industry insider recently said: “The international Hemp import / export business while young, is poised to BOOM in the United States. At the present date, importation of Hemp products consists mostly of CBD isolate for two important reasons.  The first reason is CBD isolate is a price dense product. When considering the S&H costs of moving a product, something of substantial size like biomass comes with logistical challenges.  While biomass is generally is worth .10 – .20 cents per gram, CBD isolate market price is around $7.5/ gram, 50x more price dense per volume.”   Active companies in the cannabis industry includes:  CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTC:CRXPF), Aphria Inc. (NYSE: APHA) (TSX: APHA), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF), Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF).

The Kush article continued: “At the present date, importation of Hemp products consists mostly of CBD isolate (because) CBD isolate is a price dense product. When considering the S&H costs of moving a product, something of substantial size like biomass comes with logistical challenges. In the future, (they) believe that there will be two main markets for exportation, CBD isolate and CBD distillate due to the high value density of CBD.  This is because the USA is poised to become an agricultural power in Hemp, and industrialization will create an opportunity for the USA to become a worldwide hub for CBD.  While flower quality Hemp will still be an export, the size of this market will be substantially smaller.

CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTCPK:CRXPF) (Frankfurt: 2FR) BREAKING NEWS:  CROP announced today it has entered into a purchase and sales agreement with World Farms Corp. to divest its interests in CROP Jamaica and XHemplar S.R.L in Italy for CAD$2,000,000 worth of equity in World Farms Corp.

CROP will be retained as advisors in relation to research and development in plant science.  The investment comprises of 10,000,000 common shares in World Farms Corp (‘WFC’). and represents a 19% ownership interest in WFC for CROP.  The XHemplar S.R.L joint venture facility covers 87,120 square feet.  CROP and XHemplar have been working with Italian agencies to import new and unique, high CBD genetics that are expected to command premium prices.

CROP JAMAICA has a five-acre property for the cultivation and extraction of cannabis. The principal local partner is Greg Douglas. During April to November 2017, Douglas was seconded to Jamaica’s Cannabis Licensing Authority (CLA) as their CEO. While there he issued the first commercial licenses.

CROP CEO, Michael Yorke, stated: “CROP has divested itself of these two international operations so that management can remain entirely focused on the expanding US operations while retaining a passive but strategic investment in an internationaly focused player offering CROP shareholders additional exposure to WFC’s global growth. The company has invested approximately $100,000 between the two projects. This represents a 2,000% return on investment for CROP and its stakeholders.

“The passing of the US Farm Bill in December 2018 has been a total game changer in terms of the vast opportunities opening up right now in the US.  We firmly believe in striking while the iron’s hot right now on our US doorstep while maintaining exposure to infantile global opportunities.”   Read this full announcement and more news for CROP Infrastructure at:   https://www.financialnewsmedia.com/news-crop/

Additional cannabis industry related developments from around the markets:

Aphria Inc. (NYSE: APHA) (TSX: APHA) On February 26, the company announced a worldwide license agreement with Manna Molecular Science, LLC (“Manna”), producers of state-of-the-art cannabis transdermal patches. Leveraging Manna’s established formulations, equipment and processes, Aphria will produce and sell patches containing cannabis oils for its established suite of medical and adult-use brands.  “As we continue to expand its use from product to ingredient, we are excited to offer innovative new ways for consumers to interact with cannabis,” said Jakob Ripshtein, President of Aphria. “As a company at the forefront of cannabis innovation, Manna Molecular Science will be an important strategic partner for Aphria. Like us, they are committed to making safe, high-quality cannabis products available to a wide array of global consumers.”

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD.TO) (OTCQX: TGODF) recently provided a detailed update on its Jamaican partner Epican Medicinals Ltd. (“Epican”).  In June 2018, TGOD purchased 49.18% interest in Epican, a fully integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. Significant progress has been made towards expanding cultivation, opening additional retail dispensaries, and establishing a leadership position in Jamaica’s robust medical cannabis market.

“We have made incredible progress in Jamaica over the past 8 months,” commented Brian Athaide, Director and CEO of TGOD. “We plan to continue opening stores throughout the country, increasing productive capacity, and expanding our leadership in Jamaica. As Trelawny comes online in phases, we will accelerate production to meet growing demand within Jamaica and export product through TGOD’s distribution channels in Mexico and beyond.”

OrganiGram Holdings Inc. (TSX-V: OGI) (OTCQX: OGRMF) recently announced it has signed a letter of intent with the Société québécoise du cannabis (SQDC).  This agreement solidifies the Company’s position as a true national player in Canada’s legal adult use recreational cannabis marketplace. Organigram now has distribution in place for all ten Canadian provinces.  “Organigram’s growth strategy has always focused on establishing a strong national footprint and building our brand presence with the Edison Cannabis line nationally,” says Greg Engel, Organigram’s Chief Executive Officer.

Namaste Technologies Inc. (TSXV: N.V) (OTCQB: NXTTF) recently announced that it has reached a mutually agreed upon settlement with Sean Dollinger resulting in Mr. Dollinger entering into an advisory relationship with Namaste providing transition support to the Company to ensure the best interests of the business and stakeholders are met (the “Agreement”). Pursuant to the Agreement, Mr. Dollinger has withdrawn his previously announced legal application against the Company and has agreed to step down from all formal roles with the Company, including as a director, which will also enable him to spend more time with his young family and pursue other opportunities. Meni Morim remains Interim Chief Executive Officer (“CEO”) of Namaste.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com (FNM) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press release issued above by CROP Infrastructure Corp. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Wednesday, February 27th, 2019 Uncategorized Comments Off on $TGODF $TGOD.V North American Hemp-CBD Imports and Exports Projected To Jump

$RIV $RIV.V $CNPOF Completes $93.5 Million Bought Deal Private Placement

TORONTO, Feb. 27, 2019 — Canopy Rivers Inc. (TSXV:RIV) (“Canopy Rivers” or the “Company”) is pleased to announce that it has closed its previously announced bought deal financing (the “Bought Deal”) of subordinated voting shares of the Company (the “Subordinated Voting Shares”) with a syndicate of underwriters (the “Underwriters”) led by CIBC Capital Markets (“CIBC”) and Eight Capital (together with CIBC, the “Joint Bookrunners”). The Bought Deal consisted of an aggregate of 13,225,000 Subordinated Voting Shares, which reflects the exercise in full of the Underwriters’ over-allotment option, at a price of $4.80 per Subordinated Voting Share (the “Issue Price”) for gross proceeds of approximately $63.5 million.

Concurrent with the Bought Deal, the Company completed the previously announced private placement (the “Private Placement” and together with the Bought Deal, the “Offering”) with Canopy Growth Corporation (“Canopy Growth”), the Company’s largest shareholder. Pursuant to the Private Placement, Canopy Growth purchased 6,250,000 Subordinated Voting Shares at the Issue Price for additional gross proceeds of $30.0 million. Prior to the Offering, Canopy Growth owned approximately 26.5% of the issued and outstanding shares of the Company on a non-diluted basis and, elected to subscribe under the Private Placement for more than its pro rata participation right. Following completion of the Offering, Canopy Growth’s ownership interest in the Company has increased to approximately 27.1% of the issued and outstanding shares of the Company on a non-diluted basis.  The Subordinated Voting Shares issued pursuant to the Private Placement are subject to a statutory hold period under Canadian securities legislation expiring on June 28, 2019, and statutory restrictions on the distribution of shares from the holdings of a control person.

The combined gross proceeds to the Company under the Offering are approximately $93.5 million. The Company intends to use the net proceeds from the Offering for follow-on investments in existing portfolio companies, new domestic and international investments, working capital and general corporate purposes.

As consideration for their services, the Underwriters received a cash fee equal to 5% of the gross proceeds of the Bought Deal and 1% of the gross proceeds of the Private Placement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in the United States. The Subordinated Voting Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state of the United States, and may not be offered or sold in the United States, or to or for the account or benefit of a U.S. person (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Canopy Rivers

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Notice Regarding Forward Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions including: the anticipated use of proceeds from the Offering; the ability of the Company to identify and pursue opportunities within the cannabis sector; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Company’s final short form prospectus dated February 21, 2019, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:

Karoline Hunter
Sr. Director, Investor Relations & Communications
Email: ir@canopyrivers.com
(416) 583-5947

Daniel Pearlstein
Executive Vice President, Strategy
Email: daniel@canopyrivers.com
(647) 475-1115

Wednesday, February 27th, 2019 Uncategorized Comments Off on $RIV $RIV.V $CNPOF Completes $93.5 Million Bought Deal Private Placement

$NETE Unified Payments Among First to Achieve ETA Self-Regulation Certification

MIAMI, FL, Feb. 27, 2019 — via NEWMEDIAWIRE — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), today announces Unified Payments is among the first companies to achieve self-regulatory certification from the Electronic Transactions Association.

The Electronic Transactions Association (“ETA”) recently announced the ETA Self-Regulation Program (“ETA SRP”) which seeks to improve security and reduce risk in the payments industry by identifying and acknowledging companies that have a deep understanding of the risks associated with financial services.  The ETA is a worldwide trade association serving more than 500 member companies within the fintech payments ecosystem.

The ETA Self-Regulation Program affirms the payments industry’s commitment to maintaining robust risk management programs and provides a benchmark for the industry.  “The ETA SRP also demonstrates to various federal regulatory bodies that the Payments industry is not only capable of self-regulation but will continue to take concrete steps to mitigate instances of abuse.”

“Being among the first payments services companies to obtain ETA SRP certification is a reflection of our commitment to excellence in our industry,” said Shawn Brown, head of risk for Net Element. “We are pleased to support this program which assures our customers and stakeholders of our dedication to utilizing best practices in every facet of our company.”

About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using various technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 and 2018 Technology Fast 500™. In 2017 we were recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

Forward-Looking Statements
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include but are not limited to (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Contact:

Net Element, Inc.

+1 (786) 923-0502

www.NetElement.com

Media@NetElement.com

Corporate Communications Contact:

NetworkNewsWire (NNW)

New York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com
Wednesday, February 27th, 2019 Uncategorized Comments Off on $NETE Unified Payments Among First to Achieve ETA Self-Regulation Certification

$GGBXF Names Randy Whitaker Chief Operating Officer

COLUMBUS, OH, Feb. 26, 2019 – Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) is pleased to announce the appointment of Randy Whitaker as Chief Operating Officer, a new position within GGB. Mr. Whitaker has over 27 years’ experience in real estate, finance, and store operations.  Mr. Whitaker joins GGB from Belk, Inc. a privately held department store with over 293 locations.

“Along with much of the GGB leadership team, I worked with Randy for many years at Victoria’s Secret,” said Peter Horvath, CEO of Green Growth Brands. “He has a phenomenal track record and is a world-class operator.  GGB continues to set itself apart from the competition because of the talent and experience of our team.  We are so pleased to welcome Randy to the team, he will be a huge asset as we drive towards creating remarkable cannabis and CBD experiences for consumers.”

In prior roles Mr. Whitaker has brought a results-oriented focus, agility in fast-paced environments, and a talent for building high-performing teams. Mr. Whitaker was most recently at Belk, Inc. as Executive Vice President, Chief Stores Officer. During that time, he led the stores organization including store operations, real estate, store design and construction, aviation, visual merchandising, customer care, credit, and supply chain. Prior to Belk, Mr. Whitaker spent over 15 years at Victoria Secret, in a variety of real estate and stores operations positions, including Executive Vice President, Store Operations. During his five years as EVP, Store Operations, Mr. Whitaker was responsible for 1,100 stores that delivered USD$6B in annual revenue while maintaining a USD$2B operating expense budget.

“GGB has done an incredible job building the foundation of the stores organization with industry leading productivity,” said Randy Whitaker, COO of GGB. “I am excited to continue this momentum and create a world class fleet of stores, shops, and eCommerce channels that will create value, year after year.”

Effective immediately, Mr. Whitaker will lead real estate, business development, store design and construction, stores, shops, eCommerce, and field operations support.

About Green Growth Brands
Green Growth Brands expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love. Led by Peter Horvath, the GGB team is full of retail and consumer packaged goods experts with decades of experience building successful brands. Join the movement at GreenGrowthBrands.com.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions.   Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Tuesday, February 26th, 2019 Uncategorized Comments Off on $GGBXF Names Randy Whitaker Chief Operating Officer

$LXRP comments on FDA Statement on Novel Nicotine Replacement Therapies

Kelowna, British Columbia / February 26, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, comments on the February 21, 2019 U.S. Food & Drug Administration (“FDA”) statement outlining the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes, and the FDA draft guidance issued: “Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products”.

Lexaria has recently partnered with a world-leading tobacco company that has licensed the Company’s DehydraTECHTM technology to develop novel oral nicotine products utilizing Lexaria’s technology that could harmonize with the evolving FDA strategy. FDA Commissioner Scott Gottlieb, M.D., issued a statement regarding additional steps by the FDA to support novel nicotine replacement therapies, which contained the following excerpts:

“More than 54 years after the landmark Surgeon General’s report on smoking and health, tobacco use – primarily cigarette smoking – remains the leading cause of preventable disease and death in the U.S., responsible for 480,000 premature deaths each year. Why? Because cigarettes are incredibly addictive.

“Most adult smokers want to quit, and nearly half try to do so every year. But nicotine, which a cigarette efficiently delivers through the lungs and to the brain in less than 10 seconds, draws many people back despite their desire to stop.

“While nicotine keeps smokers addicted, it’s the smoke and the 7,000 chemicals contained in it that causes the disease and death. That’s why a key element of our comprehensive plan to significantly reduce tobacco-related disease and death is recognizing that nicotine, while highly addictive, is delivered through products along a continuum of risk with combustible cigarettes at one end, and nicotine replacement therapy (NRT) products at the other. In particular, NRT products, which are designed to safely reduce withdrawal symptoms, including the nicotine craving associated with quitting smoking, are generally considered to double the likelihood of a successful quit attempt. Quitting smoking can lower a person’s chances of having lung disease, heart disease or getting certain types of cancer.

“Most existing NRTs such as gums, patches and lozenges have been approved for more than 30 years. They have played an important role in providing adults with tools to help quit smoking, in a manner that doesn’t require cutting themselves off immediately and entirely from nicotine. Now, we have an opportunity to build on these NRTs, with novel products that may provide an opportunity to save even more lives by empowering adults to safely and effectively quit smoking.

“Novel products with different characteristics or routes of nicotine delivery have the potential to offer additional opportunities for health-concerned smokers interested in quitting.”

The entire FDA statement can be found here, or at www.fda.gov.

The FDA has also issued draft guidance for industry “Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products” to assist sponsors in the clinical development of nicotine replacement therapy drug products. The guidance reflects the FDA’s current recommendations regarding overall development programs to support NRT drug products for smoking cessation and related chronic indications.

As previously announced on January 15, 2019, Lexaria has partnered with the world’s most progressive tobacco company that has licensed DehydraTECH and is funding pioneering research and development (“R&D”) into novel methods of delivering nicotine without the risks of combustion. Positive results of this R&D program could provide nicotine products that help to meet the goals elucidated within the FDA’s statement and guidance, especially relating to oral administration. Lexaria Nicotine LLC will earn royalties on DehydraTECH enabled products sold by its partner tobacco company.

Lexaria has already demonstrated that its patented DehydraTECH technology is effective at delivering nicotine to the bloodstream, in an edible format, in as little as 2 minutes in animal tests reported on August 7, 2018. That same study showed Lexaria’s technology delivered 90.2% more nicotine by the 10-minute mark of the study (95% CI; p=0.044) compared to a positive control. Furthermore, nicotine quantities delivered into the brain using its technology ranged from 195%-560% greater than controls with peak concentrations achieved as much as four times faster. Collectively, these results demonstrated the ability of Lexaria’s technology to improve nicotine delivery efficiency relative to conventional oral administration. Lexaria is highly confident that DehydraTECH has the potential of meeting FDA goals of reducing the quantity of nicotine in each serving while still satisfying the consumer.

As the FDA has noted within its statement, most smokers fail to quit cigarette smoking despite their desire to do so. Lexaria is of the view that most smokers require an effective alternative nicotine delivery method to empower them to make their best personal choice related to nicotine use. It is widely understood that it is the inhalation of combusted gases and chemicals involved in burning cigarettes that is responsible for most adverse health consequences related to smoking.

Lexaria’s technology could offer a method of delivering nicotine that preserves consumer choice, avoids the most serious health consequences of smoking cigarettes, and harmonizes with current FDA policies. As such, Lexaria supports the FDA statement on novel nicotine replacement therapies.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250)765-6424 Ext 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

Tuesday, February 26th, 2019 Uncategorized Comments Off on $LXRP comments on FDA Statement on Novel Nicotine Replacement Therapies

$TGODF How the 2019 Academy Awards Rolled out the Carpet for CBD Stocks

CBD made headlines at the 2019 Academy Awards.In fact, actress Melissa McCarthy reportedly applied CBD oil to her feet to alleviate the pain she anticipated from high-heel shoes. In addition, according to Allure, stylist Kate Young also uses cannabis-based numbing cream with her celebrity clients, as well.

“Applying CBD half an hour before wearing shoes, especially high heels, is very effective because it acts as an analgesic and anti-inflammatory, so it reduces pain and swelling,” Lord Jones’ co-founder and president Cindy Capobianco told Yahoo Lifestyle.

“Many of our customers apply the product and then put on a pair of socks to help lock in the hydrating benefits as they apply makeup or finish getting dressed. For the most part, one application before going out has proven to be very effective.”

Interest in using CBD has only grown, as medical studies prove its health benefits. In fact, it can help treat psoriasis, dermatitis, and even minimize seizures, and stress.

Some of the companies that are already benefiting from CBD interest include The Yield Growth Corporation (CSE:BOSS)(OTCQB:BOSQF), The Green Organic Dutchman (TSX:TGOD)(OTC:TGODF), and Aleafia Health (TSXV:ALEF)(OTC:ALEAF).

The Yield Growth Corporation’s (BOSS)(BOSQF) subsidiary, Urban Juve Provisions Inc., had its products selected for inclusion in gift bags given to the Awards presenters during a pre-Oscars event at the Four Seasons Hotel Los Angeles at Beverly Hills on Saturday.

The bags included Urban Juve’s unisex lip balm and anti-aging serum, both of which are infused with hemp root oil extracted using the company’s patent-pending method.

“The opportunity to connect with this year’s awards presenters is an exciting one for Urban Juve. We’ve received tremendous interest in the Urban Juve product line and are pleased to have the opportunity to introduce this influential group to our Ayurvedic products,” says Urban Juve president Sandi Lesueur. “This is a unique opportunity to gain exposure for our hemp-root oil infused goods, further generating interest and understanding of our unique products.”

For More Information on The Yield Growth Corporation, Click Here.

The Green Organic Dutchman (TSE:TGOD)(OTC:TGODF) is developing a distribution hug for large-scale beverage and edible products that can be introduced in Canada and abroad.

“We believe that the beverage and edible market will be the largest single segment of the cannabis market. Cannabis, as the base ingredient, makes these products possible. The medicinal and recreational market for CBD and THC will only increase over time and starting with an organic input is the most important aspect to developing these higher margin products,” notes TGOD President Csaba Reider.

For More Information on The Green Organic Dutchman Holdings Ltd., Click Here.

Aleafia Health Inc. (ALEF)(ALEAF) recently acquired Emblem Corporation in an all-stock deal valued at $173.2 million. The company’s Canabo Medical Clinic and Emblem’s GrowWise Health will combine and now serve nearly 60,000 patients with 40 national medical clinics.

“The Emblem acquisition rapidly accelerates the execution of Aleafia’s strategy to become a vertically integrated, diversified cannabis company. It is difficult to overstate the significance of securing the highest quality medicine for our patients and Aleafia,” said Aleafia Health CEO Geoffrey Benic. “Emblem’s product leadership in the medical and adult-use sectors and highly coveted supply agreements will perfectly complement Aleafia’s cannabis production and clinic operations. This is a transformative transaction.”

For More Information on Aleafia Health Inc., Click Here.

MarijuanaStox.com is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news.

MarijuanaStox.com is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of MarijuanaStox.com) and The Yield Growth Corp, Winning Media has been paid four thousand dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.

Contact Information:
2818047972
ty@marijuanastox.com

Tuesday, February 26th, 2019 Uncategorized Comments Off on $TGODF How the 2019 Academy Awards Rolled out the Carpet for CBD Stocks

$LXRP Plans Additional Clinical Trials Following Successful Tests

  • Company recently announced significant findings of cardiovascular performance improvements with TurboCBD
  • Lexaria plans additional human clinical trials of CBD
  • Company is now moving forward with clinical studies on oral forms of nicotine delivery following a large investment agreement

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a food bioscience company that developed and commercialized cost-effective drug delivery platform DehydraTECH. This technology enhances the performance of beneficial compounds in ingestible products. Currently, Lexaria has patents pending worldwide for use of the technology in a range of bioactive molecules, including cannabinoids, nicotine, NSAID pain relievers and more. Leveraging this platform, the taste, smell, speed of action, bioabsorption and bioavailability of oral ingestion is improved without the harmful practices of lighting up or the unhealthy additions of sugars and sweeteners. The company licenses DehydraTECH to other companies around the world to enhance already established, quality product lines.

TurboCBD is Lexaria’s proprietary DehydraTECH-powered, CBD-fortified hemp-oil capsule. The capsules are formulated with full-spectrum hemp oil, ginseng and ginkgo for enhanced focus and…

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, February 25th, 2019 Uncategorized Comments Off on $LXRP Plans Additional Clinical Trials Following Successful Tests

$TGODF $TGOD.V Increases Operating Capacity at Hamilton Facility

Cannabis-focused research and development company the Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) recently issued an update regarding the construction at its Valleyfield, Quebec, and Hamilton, Ontario, facilities. A recent article discussing the company reads, “Regarding the Hamilton operations, TGOD has modified major systems from the original design. Furthermore, the company has re-engineered the whole harvesting process to enhance production uptime and facility throughput. Therefore, this has resulted in increased productive capacity from 14,000 kg to 17,500 kg. TGOD has grown and successfully harvested numerous crops in the pilot facility. It has also stored product for its forthcoming medical pilot launch. . . . In a news release, Brian Athaide, TGOD’s chief executive officer, said, ‘Not only have we addressed the important redesign requirements, we have also made significant improvements to the operating capacity and capital timing of our facilities, resulting in an additional 46,500 kgs of productive capacity.’”

To view the full article, visit: http://nnw.fm/8Uf3G

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, February 25th, 2019 Uncategorized Comments Off on $TGODF $TGOD.V Increases Operating Capacity at Hamilton Facility

$NETE 420 with CNW Legalization’s Impact on Medical Cannabis Programs

You may be wondering what becomes of the medical marijuana programs and products once a jurisdiction legalizes recreational pot. Some people even conclude that medical marijuana dies quietly once recreational cannabis becomes legal. Is this true?

It may be true that the process of getting a medical marijuana card is a bit cumbersome (find a doctor willing to recommend medical marijuana for your health challenge, then apply and pay license fees, etc.). The legalization of recreational cannabis means that access to marijuana now just requires you to present a valid government-issue photo ID at a dispensary or retail outlet in order to buy cannabis. Viewed from this angle, some patients may opt to buy recreational marijuana and use it to manage their symptoms.

However, one key reason why the legalization of recreational cannabis cannot mark the death of medical marijuana is that patients often require customized or specially formulated cannabis products to manage their symptoms or treat the qualifying conditions for which they were enrolled on the medical cannabis program. For this reason, the commencement of recreational sales cannot signal doom to medical cannabis.

Secondly, the legalization of recreational weed also boosts medical cannabis because it widens the market for marijuana products. That wider market generates a lot of interest among researchers and business entities. Consequently, more research will be conducted, and this research can result in a better understanding of how cannabis can be used to treat different conditions. This is clearly happening in Canada where recreational sales have sparked greater interest among cannabis researchers and innovators.

Thirdly, players in the cannabis industry may be unwilling to turn their backs upon their medical cannabis clients because these patients are more reliable clients when compared to recreational users. You see, a patient needs medical cannabis while cannabis is just a want to a recreational user. This means that addressing the needs of patients results in more assured business when compared to chasing the wind as you try to keep up with the fickle interests of recreational users. From a business perspective, medical cannabis ensures steady sales so it will stay despite the legalization of recreational sales.

More importantly, recreational cannabis normalizes medical cannabis. Patients are often viewed as disguised stoners in jurisdictions where only medical cannabis is legal. However, the end of cannabis prohibition often results in more information becoming available to people in that area. Consequently, they will develop a greater appreciation of the medical benefits of cannabis and patients will no longer have to be on the defensive as they use medical cannabis.

As you can see, the end of cannabis prohibition doesn’t necessarily mean that medical cannabis programs will suffer a slow death. MustGrow Biologics Corp. and Net Element, Inc. (NASDAQ: NETE) insist that different people have different needs, so it may not be right to think that the commencement of recreational sales means the death of medical cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Monday, February 25th, 2019 Uncategorized Comments Off on $NETE 420 with CNW Legalization’s Impact on Medical Cannabis Programs

$TGODF Provides Jamaican Operations Update

TORONTO, Feb. 22, 2019  – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to provide a detailed update on its Jamaican partner Epican Medicinals Ltd. (“Epican”).

In June 2018, TGOD purchased 49.18% interest in Epican, a fully integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. Significant progress has been made towards expanding cultivation, opening additional retail dispensaries, and establishing a leadership position in Jamaica’s robust medical cannabis market.

HIGHLIGHTS

  • Leased a 100-acre parcel of land in Trelawny Parish, with land clearance underway to increase production with a 2,000 kg pilot towards a 14,000 kg operation. The 14,000 kg is expected to utilize approximately 5% of the property with the potential for expansion as demand dictates
  • Accelerated productive capacity while building inventory in advance of planned retail expansion
  • Pursuing GMP certification at the Kingston Lab to facilitate global export
  • Epican’s flagship ~4,000 sq. ft. Kingston retail location opened in July 2018 and has experienced continual month over month sales growth. Epican will soon open a Café adjacent to the retail store expanding initiatives to include cannabis-related events such as Puff and Paint and Cannabis Yoga
  • Secured strategic locations in Montego Bay (on the “Hip Strip” Gloucester Ave.) and Negril (close to the world-famous “Rick’s Café”) for the planned second and third retail locations.  The Montego Bay retail location is complete and ready to open pending authorization from the Cannabis Licensing Authority (“CLA”). Additional locations, including Negril, are planned for 2019 and 2020
  • Expected to dramatically reduce delivery times across the island, Epican is piloting an industry first prescription delivery service for registered medical patients with a view to expand across the country subject to pilot success
  • Testing the first high-technology cannabis vending machines including thumbprint scanners ensuring product access only to authorized patients
  • Sponsored cannabis “Herb Cure” pavilion of the 2019 “Rebel Salute” music festival
  • Increased employees from 17 to 40

Jamaica has long been recognized as a premier location for cannabis enthusiasts and Epican has deep roots in the country. Founders, the McKenzie brothers, have been at the forefront of the nation’s burgeoning medical cannabis industry, including extensive advocacy for the responsible development of the industry. Epican was awarded the country’s historic first cultivation license and continues to forge the path to serving the medical needs of the country’s 3 million inhabitants and nearly 4.3 million tourists each year.

“We have made incredible progress in Jamaica over the past 8 months,” commented Brian Athaide, Director and CEO of TGOD. “We plan to continue opening stores throughout the country, increasing productive capacity, and expanding our leadership in Jamaica. As Trelawny comes online in phases, we will accelerate production to meet growing demand within Jamaica and export product through TGOD’s distribution channels in Mexico and beyond.”

The 49.18% Jamaican investment is an integral component of TGOD’s international strategy, together with distribution and operations in Europe, Latin America and North America provide the Company with a strong foundation to rapidly expand organic initiatives across the globe.

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about future facility construction and capital costs, statements about production timing, efficiencies, capacities and ramp-up, statements about future production, revenue and cashflows, statements about the offering of any particular products by the Company in any jurisdiction, statements about the success of any GMP applications, statements about the timing or success of any retail store launches or activities, statements about future prescription delivery services, statements about future export activities, and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Friday, February 22nd, 2019 Uncategorized Comments Off on $TGODF Provides Jamaican Operations Update

$NUGS Expands Portfolio with Cannabis Brands around the World

  • The cannabis industry is currently a $10 billion market and is expected to increase its economic vitality in coming years
  • Cannabis Strategic Ventures recently acquired Worldwide Staffing Group, which works within the company as a wholly and separately owned subsidiary, adding to its staffing capabilities
  • An increased demand for staffing within the burgeoning cannabis industry could prove beneficial for Cannabis Strategic Ventures’ influence in the market

Cannabis Strategic Ventures Inc. (OTC: NUGS), a publicly traded corporation that cultivates and partners with brands around the world to build category leaders within the cannabis and CBD marketplace, is utilizing a diverse approach to create profitable opportunities across all corners of the market. While primarily outsourcing personnel solutions, the company also seeks investment opportunities in real estate, cultivation, extraction, distribution, packaging, dispensary operations and branded products within the cannabis marketplace.

The future of cannabis is booming, and the $10 billion industry is attracting businesses of all types. Companies ranging in products and services from energy efficiency technology to health and…

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, February 22nd, 2019 Uncategorized Comments Off on $NUGS Expands Portfolio with Cannabis Brands around the World

$LXRP 420 with CNW – Four Ways Cannabis Entrepreneurs are Using AI in Sales and Ecommerce

As the marijuana industry has grown and become more widely accepted, many tech companies have introduced new products to enable the cannabis industry. Here are the four major AI products that marijuana businesses are deploying to boost sales and make ecommerce more successful.

Chatbots

The explosion of interest in cannabis means that the limited staff of marijuana companies can easily be overwhelmed if they decided to address each person’s queries without the help of AI.

Chatbots have been introduced to engage customers and potential customers quickly and efficiently by providing all the information one needs. For example, the chatbot can take a potential customer through the different cannabis strains that may help to ease the symptoms that the client is experiencing. These bots have revolutionized the way cannabis businesses attend to their customers at a time when people make a query and expect an answer to it “yesterday.”

Finding Leads

One of the hardest aspects of selling is to find prospects. Cannabis businesses are turning to AI tools, such as Node, to generate lists of potential customers. This is a more reliable method than the traditional way of buying lists of prospects who often turned out to be uninterested in what one was selling.

Filtering Prospects

It is one thing to get a list of prospects and it is another matter to filter them into warm or cold prospects. That is where AI comes in. Artificial intelligence systems are now available to analyze data in order to establish which particular products a potential customer has been searching for.

The findings of such AI systems can help sales personnel to concentrate their efforts on those individuals that are most likely to make a purchase instead of spending time and effort on people with a low possibility of making a purchase. An example of this type of AI system is Netra. This system understands consumer preferences by analyzing the visual content on different social media platforms.

Sales Forecasting

As you may know, there is always a multitude of demands competing for the resources that any company has at its disposal. The same applies to cannabis businesses. One of the best ways to determine how to allocate those scarce resources is by forecasting sales so that intelligent decisions can be made for the company.

AI systems have been deployed to forecast cannabis sales so that businesses can plan for the future more effectively, such as by making decisions on when to scale up or down.

While some people may think that AI has come to take cannabis jobs, the truth is that AI can only go so far. For example, AI fails dismally at comprehending the nuances of language based on different contexts and humans have to step in at such points. Cannabis businesses should therefore regard AI as an aid to their workforce rather than as a tool to cut back on human employees. Green Hygienics Holdings Inc. (OTCQB: GRYN) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) look forward to seeing even more AI products in every aspect of the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Friday, February 22nd, 2019 Uncategorized Comments Off on $LXRP 420 with CNW – Four Ways Cannabis Entrepreneurs are Using AI in Sales and Ecommerce

$GGBXF Opens CBD Shops in Indiana and Tennessee Malls

COLUMBUS, OH, Feb. 21, 2019 – Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) is pleased to announce the opening of two new Seventh Sense CBD shops, located in Glenbrook Square, Fort Wayne, Indiana and in Hamilton Place, Chattanooga, Tennessee. These new shops represent the next step in Green Growth Brands’ plan to dominate CBD retailing and planned network of hundreds of shops designed to serve customers across the United States.

Earlier this month, Green Growth Brands announced the opening of its first Seventh Sense CBD Shop at the Fayette Mall in Lexington, Kentucky and the launch of its eCommerce website ShopSeventhSense.com.

“We know that the stickiest customers come from in-store experiences,” said Peter Horvath, CEO of Green Growth Brands. “In our growing network of shops, we are committed to providing compelling assortments of products that encourage our customers to explore. Early results have seen Seventh Sense products selling though at three-times the typical performance of personal care products, accomplished with never-seen-before brands and zero marketing beyond point of sale. We could not be happier with the way the brand and the network are growing.”

As previously announced, GGB intends on partnering with a variety of developers to sign lease agreements for prime real estate throughout America and is having very encouraging discussions with a number of well-known property groups. The shop in Glenbrook Square, Fort Wayne, Indiana will be approximately 200 square feet in size, and is the first space leased by GGB from Brookfield Properties. The shop in Hamilton Place, Chattanooga, Tennessee will be approximately 180 square feet in size, and is the second space leased by GGB from CBL Properties.

The Seventh Sense CBD shop retails high-quality botanical therapy CBD-infused personal care and beauty products at affordable prices. The ever-expanding product offering includes CBD-infused body lotion, muscle balm, body wash, bath salts, sugar scrub, bath bomb, lip balm, and face oil.

About Green Growth Brands
Green Growth Brands expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love. Led by Peter Horvath, the GGB team is full of retail and consumer packaged goods experts with decades of experience building successful brands. Join the movement at GreenGrowthBrands.com.

Cautionary Statements:
Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Thursday, February 21st, 2019 Uncategorized Comments Off on $GGBXF Opens CBD Shops in Indiana and Tennessee Malls

$LXRP Cardiovascular Performance Improvements DehydraTECH TurboCBD

KELOWNA, BC / February 21, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ”Company” or ”Lexaria”), a drug delivery platform innovator, is pleased to announce additional significant findings upon completion of further data analyses from its 2018 randomized, placebo-controlled, double-blinded European human clinical study that evaluated TurboCBD, the Company’s proprietary, DehydraTECH powered, cannabidiol (”CBD”) fortified hemp-oil capsule.

A single 90mg dose of TurboCBD provided evidence of lower blood pressure; higher blood flow to the brain; faster delivery onset of CBD into the bloodstream; and, larger quantities of CBD within the blood compared to a single 90mg dose of generic CBD.

Key metabolic and hemodynamic performance findings linked to bioavailability enhancements were revealed in the study, which compared a 90 mg dose of Lexaria’s TurboCBD to a 90 mg dose without Lexaria’s DehydraTECH technology (the ”positive control”) as well as a placebo, as follows:

  • Analysis of mean arterial blood pressure (MAP) at peak blood levels of CBD achieved with Lexaria’s TurboCBD™ demonstrated a significant reduction in MAP compared to placebo (95% CI; p=0.027). This finding was not observed with the dose-matched positive control formulation for which there was no significant decrease in MAP compared to placebo (95% CI; p=0.625);
  • Cerebral perfusion was also analysed by an index of conductance in the middle cerebral artery (MCA). The findings revealed that Lexaria’s TurboCBD caused the greatest increase in MCA conductance relative to both the positive control formulation and placebo (95% CI; p=0.017 and P=0.002 respectively);
  • Finally, over the six-hour study, analysis of the total area under the curve (AUC) demonstrated that Lexaria’s TurboCBD resulted in a notable trend for higher levels of CBD in the bloodstream overall than the positive control formulation with total AUC of 10,865 ± 6,322 observed with Lexaria’s formulation compared to 7,115 ± 2,978 observed with the positive control (95% CI; p=0.096). Furthermore, when normalized to body mass, the AUC at the peak CBD concentration was markedly and significantly (95% CI; p=0.02) higher with the TurboCBD™ 90 mg dose compared to the 90 mg dose positive control formulation.

On August 1, 2018, the Company reported data from this study that demonstrated much faster absorption of CBD in the subjects within the first 30 minutes of the study as well as higher bioavailability throughout the course of the study. The additional results announced today provide additional support for the pronounced effectiveness of Lexaria’s DehydraTECH technology at enabling superior cannabinoid delivery upon ingestion. The significant MAP results suggest potential utility of Lexaria’s technology for CBD-induced reduction of blood pressure, while the enhanced MCA conductance also supports previous pre-clinical findings demonstrating the ability of Lexaria’s technology to enhance drug delivery to the brain tissues as a principal site of action for compounds like cannabinoids.

”The findings that Lexaria’s DehydraTECH technology can enable superior cannabinoid delivery are unique in this healthy-human clinical trial. However, the findings that the technology can proffer a positive influence on blood pressure and perfusion to the brain are truly remarkable,” said Professor Philip Ainslie, Ph.D., Principal Investigator and Co-Director of the Centre for Heart, Lung and Vascular Health, UBC Okanagan Campus, Kelowna, Canada. ”The potential benefits of this approach, but over the acute and more chronic time periods, in more middle-aged or elderly populations should now be prioritized. Establishing the impact of CBD delivery on the health of the circulatory systems, including the brain, could have major implications for the adjunct treatment of high blood pressure and some neurological diseases.”

The study also provided exploratory findings with respect to relative levels of several CBD liver metabolites that were analysed for all subjects. Levels of 6α-OH-CBD, 7-OH-CBD, and 7-CBD-COOH were distinctly lower, albeit not statistically, initially in all cases and throughout the course of the study in two cases. These findings are aligned with Lexaria’s theorized DehydraTECH mechanism of action whereby it is believed to stimulate lymphatic drug uptake and routing to the systemic circulation bypassing liver metabolism to some degree as the basis for its rapid and pronounced effectiveness.

Based on the positive outcomes of this study, Lexaria intends to conduct further human clinical investigations within the next year using DehydraTECH for cannabinoids with expanded numbers of subjects over a wider age range and selected pathologies. Additional data and reports will be provided from future studies as they become available.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.
Alex Blanchard, Communications Manager
(250) 765-6424 Ext 202

Or

NetworkNewsWire (NNW)
www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

Thursday, February 21st, 2019 Uncategorized Comments Off on $LXRP Cardiovascular Performance Improvements DehydraTECH TurboCBD

$PFSF Partnership with Brazilian Trade Association Big for BOAPIN Blockchain Trading Platform

  • PFSF is partnering with FIERO, a leading Brazilian trade association
  • The company’s proprietary BOAPIN trade portal streamlines information with multilingual communication, marketing logistics and cross-border payment solutions
  • PFSF is also working toward integrating its platform with the internet of things

Pacific Software Inc.’s (OTC: PFSF) proprietary BOAPIN cross-border blockchain trading platform is the centerpiece of its new partnership with China and FIERO. FIERO is a leading Brazilian trade association focused on developing and promoting the economy of Rondônia, a regional state within Brazil (http://nnw.fm/Us7Fn). The partnership with FIERO may play a key role in what could become an expanded opportunity for PFSF throughout South America (http://nnw.fm/biN32).

BOAPIN is an e-commerce trade platform designed to foster streamlined information between China and agricultural suppliers in Brazil through its marketing logistics, smart contract technology, product certification, cross-border payment solutions and…

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, February 21st, 2019 Uncategorized Comments Off on $PFSF Partnership with Brazilian Trade Association Big for BOAPIN Blockchain Trading Platform

$VVCIF Hemp-CBD Infused Products Craze Picking Up Momentum

Palm Beach, FL – (February 21, 2019) – U.S. and Canadian cannabis companies, witnessing the CBD-rush, have started developing their own strategies to tap the plant’s potential. Just recently, Canopy Growth Corp. announced it would spend $150 million to set up a hemp facility in New York state, where hemp-derived CBD would be extracted and sold to consumers there.  If CBD becomes one of the biggest priorities for a cannabis company in North America, then many believe going the hemp route could just be the cheaper option. An increasing number of wellness products are now promoting CBD, a part of the cannabis plant proponents say is rich in medical benefits as an anti-inflammatory and anxiety reducer. Emboldened by the federal legalization of hemp — from which many CBD products are based — oils and CBD-infused waters have started showing up in local stores and even restaurants.   Active companies in the markets this week include The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), VIVO Cannabis Inc. (TSX-V: VIVO) (OTC: VVCIF), Emerald Health Therapeutics, Inc. (TSX-V: EMH) (OTC: EMHTF), iAnthus Capital Holdings, Inc. (CSE: IAN) (OTC: ITHUF), CV Sciences, Inc. (OTC: CVSI).

In a recent Motley Fool article it was reported China led all countries in 2018 with almost $1.2 billion in hemp sales, followed by the U.S. at $1 billion, all of Europe at $980 million, and the combination of Central and South America at $220 million. However, by 2022, New Frontier Data’s report estimates U.S. hemp sales will have jumped to $2.6 billion, representing a compound annual growth rate of 27%. Of this $2.6 billion in hemp sales, half ($1.3 billion) will be generated from hemp-derived CBD products.

The Yield Growth Corp. (CSE:BOSS) (OTCPK:BOSQF) BREAKING NEWS:  Yield Growth Corp is pleased to announce that it has completed formulations and initial testing for 10 new products to be infused with cannabinoids: 4 facial skin care products, 4 essential oil wellness blends and 2 foot creams.

Yield Growth subsidiary Urban Juve has developed 4 new products that it intends to add to the Urban Juve product line later this year. These include an eye cream, a cream cleanser, a liquid face cleanser and facial cleanser pads. Each of these products has been created using the highest quality natural ingredients.

Further, Urban Juve has developed 4 exotic essential oil wellness blends for everyday use.  These blends contain Urban Juve’s patent pending hemp root oil which promotes superior transdermal absorption.  They are tentatively entitled “Energy Boost”, “Headache”, “Sleep” and “Stress”.   All are designed to easily be blended with THC or CBD oils…  … Yield Growth subsidiary UJ Topicals  has developed two foot creams that are intended to be infused with cannabinoids. The first is intended to relieve pain and provide moisturizing for dry, cracked feet.  The second cream is intended to contain a higher concentration of  THC to relieve pain from blisters, bruises, inflammation, sore heels, bunions, corns or calluses. UJ Topicals next steps are to infuse the creams with THC through licensed cannabis manufacturers so that the products can be brought to market.      Read this and more news for The Yield Growth Corp. at:  https://www.financialnewsmedia.com/news-boss

Other recent developments and major influences in the healthcare/biotech industry include:

Pyramidion Technology Group, Inc. (OTCPK:PYTG) On February 20, the company announced that during the final quarter of 2018, Pyramidion Technology Group, Inc. (PYTG) (PYTG) acquired NxGen Brands, LLC and became the proud owner of LeafyWell (LeafyWell.com), and shortly thereafter announced the finalization of a contractual agreement to provide custom cannabidiol (CBD)-product formulations to Emergent Health, Corp., including the first product of its kind for both companies consisting of an ingredient trifecta designed to aid in sleep, anxiety, and mood: CBD, Melatonin, and GABA. Additionally, during the final quarter of 2018, PYTG announced the execution of a binding letter of intent to acquire Renaissance Health Publishing, LLC. – a private Florida-based company specializing in health and wellness supplements.

Carlos Hurtado, CEO of PYTG, stated, “We anticipate that our current shareholders will be equally elated to learn the news that we are on target to successfully surpass our final-quarter 2018 revenues of our CBD hemp-derived supplements, including those manufactured by LeafyWell, solely during this short period of time in 2019. As a company, we expect to continue to move forward on many fronts, and we expect that this news is just the tip of the iceberg of what is ahead in a big way.”

VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQX: VVCIF) On February 11, the company, a licensed cannabis producer offering premium medical and adult-use products and services,  announced that the Company’s subsidiary, ABcann Medicinals Inc. (“ABcann”), has received approval from Health Canada for its most recent license amendment request allowing for the sale of cannabis oil.

The cannabis oil sales license allows the Company to significantly expand its product lines for medical cannabis patients and adult-use consumers. ABcann’s high-quality oil products are expected to be a core component of the Beacon Medical™ and Lumina™ brands, in addition to the cannabis oil already offered by the Company’s Canna Farms™ brand.

Emerald Health Therapeutics, Inc. (TSX-V: EMH) (OTCQX: EMHTF) On February 20, the company announced the launch of Verdélite Sciences Inc. (“Verdélite”), a wholly-owned, Québec-based production subsidiary licensed by Health Canada. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes.

Emerald is nearing completion of its over $100 million investment to secure and expand its multi-purpose facility to 88,000 square feet and enable the complete cycle of indoor cultivation, product development and automated packaging of cannabis products. Upon reaching full production levels in mid-2019, Verdélite projects it will have created approximately 140 jobs.

iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF) On February 20, the company, which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, announced that it has opened its second New York dispensary, located in the Dutchess County town of Wappingers Falls. The dispensary will operate as “Citiva Hudson Valley” under iAnthus’ “Citiva” New York dispensary brand.

The 2,600 sq. ft. dispensary is located at 1147 Route 9 in Wappingers Falls, a short drive from Beacon Train Station on the Metro-North Railroad, Marist College, Vassar College, and a collection of New York historical sites. The retail location initially will offer more than 30 locally-sourced, lab-tested products, including vape cartridges, tinctures, capsules, and powders, dispensed by highly-knowledgeable patient care representatives.

CV Sciences, Inc. (OTCQB: CVSI) On February 20, the company, a preeminent supplier and manufacturer of industry-dominating hemp CBD brand, PlusCBD Oil™, announced that its best-selling product, PlusCBD Oil™ Gold Softgels, has been named a “Top Pick” by ConsumerLab.com, LLC (CL), a leading provider of independent test results for the supplement industry. PlusCBD Oil™ Gold Softgels received this recognition based on the product’s industry-leading purity and value, as well as its label accuracy.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press releases issued by The Yield Growth Corp. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Thursday, February 21st, 2019 Uncategorized Comments Off on $VVCIF Hemp-CBD Infused Products Craze Picking Up Momentum

$PBIO Proprietary Ultra Shear Platform Benefits Confirmed for CBD Processing

Laboratory Testing Shows UST-Prepared CBD Oil Solutions Meet Challenging Nanoemulsion Specifications and Exhibit Minimal CBD Loss During Processing

SOUTH EASTON, MA / February 21, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries. The Company today announced that analytical testing on hemp-derived CBD oil processed via PBI’s Ultra Shear Technology™ (UST™) platform has confirmed that UST processing uniquely achieves the challenging criteria for creating highly-effective “nanoemulsions” of CBD oil in water, without loss or modification of CBD throughout the entire UST process (> 99% recovery).

The ultimate goal in mixing oil-based nutritional and therapeutic products like CBD oil into water, for effective oral or topical delivery and absorption, is to reduce the size of the oil drops to such a level that they seemingly “vanish” into the water (become “water soluble”). These exceedingly small, nanometer-scale droplets are so tiny that it becomes very easy for the human (or other animal) body to absorb the oil-based nutrients or drugs (like CBD) directly from the inner surface of the oil droplet. Traditional processing methods struggle mightily with this challenge, but PBI’s proprietary UST platform uses ultra-high pressure to create extreme shearing forces to make nanometer-scale droplets of fluids that become highly-stable, homogenized “nanoemulsions” of materials that normally do not mix (e.g., CBD oil and water).

Dr. Vera Gross, Director of Applications Development at PBI, explained: “We asked an independent, university-affiliated laboratory to determine the size of oil droplets achieved in UST-processed CBD oil, using a universally-accepted sizing method called DLS. Their analytical results revealed that the UST- processed oil drops were reduced to approximately 65 nm in size, well into the 20-200 nm range targeted for truly effective nanoemulsion delivery and absorption of nutrients and therapeutics, such as CBD (Nano- and Microscale Drug Delivery Systems, 2017).”

Dr. Gross continued: “It was critically important to also demonstrate that CBD from hemp-derived CBD oil was not lost or modified during UST processing. For this we enlisted the help of scientists at NutraFuels, Inc. (OTCQB: NTFU), which has an FDA-inspected, highly-qualified analytical testing laboratory with state-of-the-art equipment and well-trained chemists with years of experience in laboratory testing.”

Mr. Cooper Dodd, R&D Scientist at NTFU, said: “Using a powerful laboratory method called HPLC to measure the concentrations of CBD and potential impurities, we determined that no appreciable amount of CBD was lost during the UST process. These results compare well to our standard processing method of ultrasonication, which can carry a risk of measurable loss of CBD, and sometimes creates the appearance of impurities if not performed properly. While there is more work to be done, as a nutraceutical manufacturer with products already on the market, we see these results as a robust leap towards better optimization of our CBD-enhanced products.”

Dr. Keith Warriner, Professor of Food Science at the University of Guelph (Toronto), and a recognized expert in the cannabis industry, commented: “The data released today on UST-generated nanoemulsions of CBD oil are very impressive. Creating nanoemulsions of CBD oil with full preservation of CBD throughout the process, while not generating impurities, remains a significant challenge in the industry. These data indicate that UST can achieve that goal, thereby offering great promise to the future.”

Professor Warriner continued: “Not only does the UST process appear capable of achieving stability of emulsions, but the controlled heating that also occurs may offer a valid alternative to thermal and non-thermal pasteurization methods to reduce the risk of harmful microbes in products such as edibles and topicals. I believe that CBD-infused topicals and similar products will prove more popular with users than edibles. However, to be successful, it is imperative that topicals be highly stable, safe, bioavailable, and readily absorbent nanoemulsions. After consideration of the data released today, the UST process appears to be a leading candidate to fill that important need.”

Dr. Bradford A. Young, Chief Commercial Officer of PBI, summarized: “We were delighted to release a short video last week showing the ability of our new UST platform to make visually clear and stable mixtures of CBD oil and water. The scientific data released today have further validated the achievement of creating high quality, nanoemulsion mixtures of oil and water using our UST platform. In particular, these data specifically show that CBD levels are preserved all the way through UST processing to the finished product. We are very excited by these results and believe our proprietary Ultra Shear Technology can help a diverse variety of customers to develop a vast array of new and beneficial products spanning multiple large markets, including CBD and nutraceuticals, cosmetics and topicals, food and beverages, drug delivery and more.”

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, we are actively expanding the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired protein disaggregation and refolding technology from BaroFold, Inc. to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (UST™) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information visit: www.pressurebiosciences.com

Forward-Looking Statements

This press release contains forward-looking statements. These statements relate to future events or the Company’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the Company’s industry results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. These forward-looking statements are made under the ”safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. These statements are only predictions based on the Company’s current expectations and projections about future events. Investors should not place undue reliance on these statements. In evaluating these statements, Investors should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause the Company’s actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report and other reports filed from time to time with the Securities & Exchange Commission (SEC). More detailed information about these risk factors are set forth in the Company’s filings with the SEC. The Company encourages Investors to review these risk factors. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Investor Contacts:

Richard T. Schumacher, President & CEO, PBI
Bradford A. Young, Ph.D., MBA, SVP & CCO, PBI
(508) 230-1828 (T) | (508) 230-1829 (F)

Thursday, February 21st, 2019 Uncategorized Comments Off on $PBIO Proprietary Ultra Shear Platform Benefits Confirmed for CBD Processing